Alibaba sharpens focus on health care

Alibaba Group will shift its Tmall online-pharmacy business to its publicly traded health-care arm in a deal valued at $2.51 billion, as it ramps its focus in that sector.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.